LIPOSORBER LA-15 System
FDA premarket approval P910018/S031 · decided 2021-07-28
Approval details
- PMA number
- P910018
- Supplement
- S031
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- LIPOSORBER LA-15 System
- Generic name
- Lipoprotein, low density, removal
- Applicant
- Kaneka Pharma America Corp.
- Date received
- 2021-06-28
- Decision date
- 2021-07-28
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- MMY
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- New York, NY
- Statement
- Introduction of parametric release into the manufacturing process for the LIPOSORBER LA-15 LDL Adsorption Column which is a component device of the LIPOSORBER LA-15 System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.